ShridarGanesanMDPhD

Associate Director for Translational Research, Chief, Section of Molecular Oncology, Omar Boraie Chair in Genomic Science

Dr. Ganesan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
195 Little Albany St
New Brunswick, NJ 08901
Phone+1 732-235-6777

Fax+1 732-235-7355

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Yale School of MedicineClass of 1993

PubMed

129 citations
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
M Palmeri, J Mehnert, A W Silk, S K Jabbour, S Ganesan
ESMO Open. 2022-02-01
283 citations
The telomerase reverse transcriptase regulates chromatin state and DNA damage responses
Kenkichi Masutomi, Richard Possemato, Judy M. Y. Wong, Jennifer L. Currier, Zuzana Tothova
Proceedings of the National Academy of Sciences of the United States of America. 2005-06-07
82 citations
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
Debyani Chakravarty, Amber Johnson, Jeffrey Sklar, Neal I Lindeman, Kathleen Moore
Journal of Clinical Oncology. 2022-04-10

Journal Articles

RET Rearrangements Are Actionable Alterations in Breast Cancer
Shridar Ganesan, Siraj M Ali, Kim M Hirshfield, Nature
PALB2 Connects BRCA1 and BRCA2 in the G2/M Checkpoint Response
Shridar Ganesan, MD, Nature
Endogenous Retrovirus Expression Is Associated with Response to Immune Checkpoint Blockade in Clear Cell Renal Cell Carcinoma
Benjamin G. Vincent, Jonathan S. Serody, Gregory Riedlinger, Shridar Ganesan, The Journal of Clinical Investigation
High-Throughput Adaptive Sampling for Whole-Slide Histopathology Image Analysis (HASHI) via Convolutional Neural Networks: Application to Invasive Breast Cancer Detection
Michael Feldman, Shridar Ganesan, John Tomaszewski, PLoS One
Join now to see all

NYU Langone Launches Molecular Oncology Program, Names LeaderOctober 11th, 2024
NYU Langone Perlmutter Cancer Center Appoints Renowned Physician–Scientist to Build & Lead Groundbreaking Molecular Oncology ProgramOctober 10th, 2024
Unraveling of Genetic Mechanism Behind Tumor Formation May Improve Targeted Treatment for Cancer PatientsAugust 10th, 2022
Join now to see all